Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to -$1.2 million.

  • Ultralife's Income from Continuing Operations fell 54695.34% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 8077.78%. This contributed to the annual value of $6.4 million for FY2024, which is 1056.38% down from last year.
  • Per Ultralife's latest filing, its Income from Continuing Operations stood at -$1.2 million for Q3 2025, which was down 54695.34% from $870000.0 recorded in Q2 2025.
  • Ultralife's Income from Continuing Operations' 5-year high stood at $3.3 million during Q2 2023, with a 5-year trough of -$1.2 million in Q3 2025.
  • For the 4-year period, Ultralife's Income from Continuing Operations averaged around $1.3 million, with its median value being $870000.0 (2025).
  • As far as peak fluctuations go, Ultralife's Income from Continuing Operations soared by 96686.57% in 2024, and later plummeted by 54695.34% in 2025.
  • Over the past 4 years, Ultralife's Income from Continuing Operations (Quarter) stood at $822000.0 in 2021, then surged by 246.72% to $2.8 million in 2023, then crashed by 91.82% to $233000.0 in 2024, then tumbled by 635.19% to -$1.2 million in 2025.
  • Its Income from Continuing Operations stands at -$1.2 million for Q3 2025, versus $870000.0 for Q2 2025 and $1.9 million for Q1 2025.